The endocrinology of aging

被引:697
作者
Lamberts, SWJ [1 ]
vandenBeld, AW [1 ]
vanderLely, AJ [1 ]
机构
[1] ERASMUS UNIV ROTTERDAM, DEPT MED, ROTTERDAM, NETHERLANDS
关键词
D O I
10.1126/science.278.5337.419
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Most aging individuals die from atherosclerosis: cancer, or dementia; but in the oldest old, loss of muscle strength resulting in frailty is the limiting factor for an individual's chances of living an independent life until death. Three hormonal systems show decreasing circulating hormone concentrations during normal aging: (i) estrogen (in menopause) and testosterone (in andropause), (ii) dehydroepiandrosterone and its sulphate (in adrenopause), and (iii) the growth hormone/insulin-like growth factor I axis (in somato-pause). Physical changes during aging have been considered physiologic, but there is evidence that some of these changes are related to this decline in hormonal activity. Hormone replacement strategies have been developed, but many of their aspects remain controversial, and increasing blood hormone levels In aging individuals to those found during mid-adult life has not been uniformly proven to be safe and of benefit.
引用
收藏
页码:419 / 424
页数:6
相关论文
共 99 条
  • [1] Use of hormone replacement therapy
    Andersson, K
    Mattsson, LA
    Milsom, I
    [J]. LANCET, 1996, 348 (9040) : 1521 - 1521
  • [2] [Anonymous], 1992, Lancet, V339, P1
  • [3] Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
    Attanasio, AF
    Lamberts, SWJ
    Matranga, AMC
    Birkett, MA
    Bates, PC
    Valk, NK
    Hilsted, J
    Bengtsson, BA
    Strasburger, CJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) : 82 - 88
  • [4] Drug therapy - Androgens in men - Uses and abuses
    Bagatell, CJ
    Bremner, WJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 707 - 714
  • [5] The epidemiology of DHEAS and cardiovascular disease
    BarrettConnor, E
    GoodmanGruen, D
    [J]. DEHYDROEPIANDROSTERONE (DHEA) AND AGING, 1995, 774 : 259 - 270
  • [6] BAULIEU EE, 1995, CR ACAD SCI III-VIE, V318, P7
  • [7] Emerging issues in androgen replacement therapy
    Bhasin, S
    Bremner, WJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) : 3 - 8
  • [8] The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
    Bhasin, S
    Storer, TW
    Berman, N
    Callegari, C
    Clevenger, B
    Phillips, J
    Bunnell, TJ
    Tricker, R
    Shirazi, A
    Casaburi, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (01) : 1 - 7
  • [9] RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS
    BLACK, LJ
    SATO, M
    ROWLEY, ER
    MAGEE, DE
    BEKELE, A
    WILLIAMS, DC
    CULLINAN, GJ
    BENDELE, R
    KAUFFMAN, RF
    BENSCH, WR
    FROLIK, CA
    TERMINE, JD
    BRYANT, HU
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) : 63 - 69
  • [10] PITUITARY-HORMONES AND AGING
    BLACKMAN, MR
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1987, 16 (04) : 981 - 994